That discovery led to dedicated weight-loss trials, where results were strong enough for semaglutide to become a major option for adults seeking help with weight management
Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment)
A correctly reconstituted solution should appear completely clear and colorless, resembling pure water without any visible particles, cloudiness, or color changes
Both the thigh and stomach (abdomen) are appropriate injection sites for Ozempic, and neither is definitively "better" than the other
Maybe some reflux, like regurgitation, like you taste your food a little bit after you eat, said Dr